| 发明名称 | Creatine oral supplementation using creatine hydrochloride salt | ||
| 摘要 | The present invention is directed to a third generation form of creatine, specifically a creatine hydrochloride salt, that drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine. | ||
| 申请公布号 | US8962685(B2) | 申请公布日期 | 2015.02.24 |
| 申请号 | US201313740909 | 申请日期 | 2013.01.14 |
| 申请人 | Vireo Systems, Inc.;Board of Regents of the University of Nebraska | 发明人 | Miller Donald W.;Vennerstrom Jonathan L.;Faulkner Mark C. |
| 分类号 | A61K31/195 | 主分类号 | A61K31/195 |
| 代理机构 | Smith, Gambrell & Russell, LLP | 代理人 | Smith, Gambrell & Russell, LLP |
| 主权项 | 1. A formula comprising: creatine HCl in an amount of about 500 mg to about 2000 mg, wherein the creatine HCl exhibits an aqueous solubility that is at least about 15 times greater than that of creatine monohydrate. | ||
| 地址 | Madison TN US | ||